Divot Substrate Templating for Islet Cell Clusters

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for islet transplantation in diabetes treatment face challenges due to the limited number of donor organs and the inefficiency of large islets, which suffer from diffusional barriers leading to cell death and reduced functionality, necessitating the development of more efficient techniques for creating viable islet cells.

Innovation Solution

A substrate with divots of specific dimensions is used to culture islet cells, allowing for the formation of small islet cell clusters that overcome diffusional barriers and improve viability and functionality, and a micro-mold device is employed to reaggregate islet cells into optimally sized clusters for transplantation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If large islets are used for transplantation, then the number of islet equivalents increases, but diffusional barriers cause cell death and reduced functionality

Engineering Contradiction:
Improvenumber of islet equivalentsVSAvoidcell viability
Core Design Contradiction:
Quantity of substanceVSReliability

Solution Approach 1:

The invention segments large islets into smaller islet clusters or individual islet cells, thereby eliminating diffusional barriers while maintaining sufficient quantity for transplantation. This segmentation allows each small cluster to receive adequate oxygen and nutrients without the core necrosis problems of large islets.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention changes the size parameter of islets from large to small clusters or individual cells, optimizing the diffusion distance for oxygen and nutrients while maintaining functional mass through increased number of clusters.

Inventive Principle:
Principle #35Parameter changes

2Reliability

If islet cells are dispersed to overcome diffusional barriers, then oxygen and glucose transport improves, but cell aggregation and functionality may be reduced

Engineering Contradiction:
Improveoxygen and glucose transportVSAvoidislet cell aggregation
Core Design Contradiction:
ReliabilityVSStability of the object's composition

Solution Approach 1:

The invention applies preliminary coating of the substrate with extracellular matrix proteins or adhesion-promoting molecules before cell seeding, which facilitates controlled aggregation of dispersed islet cells into functional clusters while maintaining adequate spacing for diffusion.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The invention uses extracellular matrix proteins or adhesion molecules as intermediaries between dispersed islet cells and the substrate, enabling controlled cell aggregation and cluster formation while maintaining optimal diffusion characteristics.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method enhances islet cell viability and functionality, leading to improved transplantation outcomes with higher insulin secretion and increased success rates, as demonstrated by the superior performance of small islet clusters compared to large islets in both in vitro and in vivo studies.

Implementation Method 1

small islet cell clusters that overcome diffusional barriers

Methodology Applied
Scientific EffectDiffusion: Diffusion

Data Source

PatentUS8895048B2Templated islet cells and small islet cell clusters for diabetes treatment
Publication Date: 2014.11.25 UNIVERSITY OF KANSAS
  • US8895048B2 patent drawing
  • US8895048B2 patent drawing
  • US8895048B2 patent drawing

AI summary

Substrates and devices for culturing cells are disclosed, along with methods of using the same. The substrates and devices include top surfaces with one or more divots disposed therein. Each divot is defined by an opening in the top surface, a rounded bottom surface spaced from the opening, and an interior side-wall surface extending between the rounded bottom surface and the opening. The top surface of the substrates and devices are optionally walled to form wells containing one or more divots. The substrates and devices may be used for reaggregating cells, for example, to form small islet cell clusters and for high throughput testing methodologies.